EGFR

You have access
CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer
SEBASTIAN GRIESING, BIN-CHI LIAO and JAMES CHIH-HSIN YANG

Anticancer Research March 2021, 41 (3) 1231-1242; DOI: https://doi.org/10.21873/anticanres.14880
You have access
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
YUTAKA YAMADA, TOMOHIRO TAMURA, YUSUKE YAMAMOTO, HIDEO ICHIMURA, KENJI HAYASHIHARA, TAKEFUMI SAITO, HIDEYASU YAMADA, TAKEO ENDO, RYOTA NAKAMURA, YOSHIHISA INAGE, HIROAKI SATOH, KESATO IGUCHI, KAZUTO SAITO, MASAHARU INAGAKI, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, MITSUAKI SAKAI, KOICHI KAMIYAMA, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, IKUO SEKINE, YUKIO SATO, YASUNORI FUNAYAMA, KUNIHIKO MIYAZAKI, TAKAHIDE KODAMA, SHIGEN HAYASHI, AKIHIRO NOMURA, HIROYUKI NAKAMURA, KINYA FURUKAWA, TAKAAKI YAMASHITA, HATSUMI OKUBO, HISASHI SUZUKI, MORIYUKI KIYOSHIMA and TAKAYUKI KABURAGI

Anticancer Research October 2020, 40 (10) 5757-5764; DOI: https://doi.org/10.21873/anticanres.14592
You have access
Targeted Therapy Followed by Cytotoxic Chemotherapy in Preoperative Patients With Locally Advanced Lung Adenocarcinoma
MASAYA AOKI, KAZUHIRO UEDA, TADASHI UMEHARA, GO KAMIMURA, TAKUYA TOKUNAGA, AYA HARADA-TAKEDA, KOKI MAEDA, TOSHIYUKI NAGATA, NAOYA YOKOMAKURA, KOTA KARIATSUMARI, YUTO NONAKA, NOBUHIRO IMAMURA, SHOICHIRO MORIZONO and MASAMI SATO

Anticancer Research May 2020, 40 (5) 2911-2916; DOI: https://doi.org/10.21873/anticanres.14268
You have access
The Histone Demethylase NO66 Induces Glioma Cell Proliferation
QING WANG, PEI Y. LIU, TAO LIU and QING LAN

Anticancer Research November 2019, 39 (11) 6007-6014; DOI: https://doi.org/10.21873/anticanres.13806
You have access
From ‘Targeted Therapy’ to Targeted Therapy
GODEFRIDUS J. PETERS

Anticancer Research July 2019, 39 (7) 3341-3345; DOI: https://doi.org/10.21873/anticanres.13476
You have access
State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA

Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484
You have access
Lapatinib Inhibits Amphiregulin-induced BeWo Choriocarcinoma Cell Proliferation by Reducing ERK1/2 and AKT Signaling Pathways
LETICIA VICOSA PIRES, YUYIN YI, JUNG-CHIEN CHENG, LOLITA SCHNEIDER PIZZOLATO, ELVIRA CORDERO, PETER C. K. LEUNG and ILMA SIMONI BRUM

Anticancer Research May 2019, 39 (5) 2377-2383; DOI: https://doi.org/10.21873/anticanres.13355
You have access
Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
ANA LAURA ORTEGA-GRANADOS, ÁNGEL ARTAL-CORTES, DAVID AGUIAR-BUJANDA, JUANA ORAMAS, JOSÉ LUIS FÍRVIDA, JAVIER DE CASTRO, JUANA CAMPILLO FUENTES, ROCÍO GORDO, RAQUEL GALÁN, JOSÉ TRIGO and on behalf of the ASPET Study Investigators

Anticancer Research March 2019, 39 (3) 1317-1328; DOI: https://doi.org/10.21873/anticanres.13244
You have access
Neoadjuvant Tyrosine Kinase Inhibition in Locally-advanced Non-small Cell Lung Cancer: Two Cases and a Brief Literature Review
ANISH B. PARIKH, LINDSAY HAMMONS and JORGE E. GOMEZ

Anticancer Research February 2019, 39 (2) 897-902; DOI: https://doi.org/10.21873/anticanres.13191
You have access
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ

Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104

Main menu

User menu

Search

EGFR

Pages